EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging‐Invisible Prostate Cancers: A Matched‐Pair Analysis

Marco Oderda, Alessandro Marquis, Luca Bertero, Giorgio Calleris, Riccardo Faletti, Marco Gatti, Luca Mangherini, Giulia Orlando, Giancarlo Marra, Irene Ruggirello, Elena Vissio, Paola Cassoni, Paolo Gontero

The Prostate · 2025-03 · 85 (4) · 374-384

DOI: 10.1002/pros.24838 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Multiparametric magnetic resonance imaging (mpMRI) is pivotal in prostate cancer (PCa) diagnosis, but some clinically significant (cs) PCa remain undetected. This study aims to understand the pathological and molecular basis for csPCa visibility at mpMRI. Methods We performed a retrospective matched‐pair cohort study, including patients undergoing radical prostatectomy (RP) for csPCa (i.e., ISUP grade group ≥ 2) from 2015 to 2020, in our tertiary‐referral center. We screened for inclusion in the “mpMRI‐invisible” cohort all consecutive men ( N = 45) having a negative preoperative mpMRI. The “mpMRI‐visible” cohort was matched based on age, PSA, prostate volume, ISUP grade group. Included patients underwent radiological and pathological open‐label revisions and characterization of the tumor mRNA expression profile (analyzing 780 gene transcripts, signaling pathways, and cell‐type profiling). We compared the clinical‐pathological variables and the gene expression profile between matched pairs. The analysis was stratified according to histological characteristics and lesion diameter. Results We included 34 patients (17 per cohort); mean age at RP and PSA were 70.5 years (standard deviation [SD] = 7.7), 7.1 ng/mL (SD = 3.3), respectively; 65% of men were ISUP 2. Overall, no significant differences in histopathological features, tumor diameter and location, mRNA profile, pathways, and cell‐type scores emerged between cohorts. In the stratified analysis, an upregulation of cell adhesion and motility, of extracellular matrix remodeling and of metastatic process pathways was present in specific subgroups of mpMRI‐invisible cancers. Conclusions No PCa pathological or gene‐expression hallmarks explaining mp‐MRI invisibility were identified. Aggressive features can be present both in mpMRI‐invisible and ‐visible tumors.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →